Organovo Holdings, Inc. financial data

Symbol
ONVO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
11555 Sorrento Valley Road, Suite 100, San Diego, CA
State of incorporation
DE
Fiscal year end
March 31
Former names
REAL ESTATE RESTORATION & RENTAL, INC. (to 10/31/2011)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 278 % -60.1%
Debt-to-equity 56.3 % +142%
Return On Equity -249 % -92.3%
Return On Assets -160 % -51.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 15.4M shares +73.9%
Common Stock, Shares, Outstanding 15.4M shares +76.2%
Entity Public Float 10.3M USD -38.2%
Common Stock, Value, Issued 15K USD +66.7%
Weighted Average Number of Shares Outstanding, Basic 18M shares +106%
Weighted Average Number of Shares Outstanding, Diluted 18M shares +106%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 103K USD -72%
Research and Development Expense 4.88M USD -49.3%
Costs and Expenses 12.9M USD -35%
Operating Income (Loss) -12.8M USD +34.3%
Nonoperating Income (Expense) 230K USD -67.4%
Income Tax Expense (Benefit) 2K USD 0%
Net Income (Loss) Attributable to Parent -12.5M USD +33.1%
Earnings Per Share, Basic -1.05 USD/shares +51.2%
Earnings Per Share, Diluted -1.05 USD/shares +51.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.17M USD -58.3%
Accounts Receivable, after Allowance for Credit Loss, Current 29K USD -47.3%
Inventory, Net 640K USD
Other Assets, Current 4K USD -94.2%
Assets, Current 4.78M USD -42.3%
Property, Plant and Equipment, Net 545K USD -32.6%
Operating Lease, Right-of-Use Asset 1.09M USD -27.8%
Assets 6.75M USD -39.5%
Accounts Payable, Current 419K USD -3.68%
Employee-related Liabilities, Current 356K USD +25.8%
Accrued Liabilities, Current 879K USD +32%
Liabilities, Current 2.41M USD +50.9%
Operating Lease, Liability, Noncurrent 660K USD -40.3%
Liabilities 3.07M USD +13.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1K USD 0%
Retained Earnings (Accumulated Deficit) -346M USD -3.77%
Stockholders' Equity Attributable to Parent 3.68M USD -56.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.68M USD -56.5%
Liabilities and Equity 6.75M USD -39.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.98M USD +43.8%
Net Cash Provided by (Used in) Financing Activities 6.25M USD
Net Cash Provided by (Used in) Investing Activities 20K USD -97.4%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 15.4M shares +76.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.29M USD
Deferred Tax Assets, Valuation Allowance 2.98M USD +21.4%
Deferred Tax Assets, Gross 3.38M USD +14%
Operating Lease, Liability 1.17M USD -26.9%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -12.5M USD +33.1%
Lessee, Operating Lease, Liability, to be Paid 1.26M USD -29%
Property, Plant and Equipment, Gross 1.93M USD -11.5%
Operating Lease, Liability, Current 513K USD +2.81%
Lessee, Operating Lease, Liability, to be Paid, Year Two 460K USD -14.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 538K USD +2.87%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 88K USD -49.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 538K USD 0%
Deferred Tax Assets, Operating Loss Carryforwards 0 USD
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 460K USD 0%
Operating Lease, Payments 517K USD +18%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 70K USD +4.48%
Deferred Tax Assets, Net of Valuation Allowance 393K USD -22%
Share-based Payment Arrangement, Expense 669K USD -69.5%